DCAT Value Chain Insights now lives on a new microsite, DCATvci.org. This site offers an enhanced user experience, including archives of all past feature articles, along with innovative advertising options for DCAT member companies.
Why advertise with DCAT Value Chain Insights?
Questions? Contact Lauryn Kuna at firstname.lastname@example.org or 1-609-208-1888 ext. 7010
DCAT Value Chain Insights (VCI) is the industry’s essential information resource from the Drug, Chemical & Associated Technologies Association (DCAT) on pharmaceutical development, manufacturing, and the supply chain.
VCI is your connection to best practices, executive insights, market trends and analysis, manufacturing activity, and regulatory developments. Delivered electronically each Wednesday, VCI is tailored for senior to mid-level executives of pharma/biopharm companies, contract manufacturers, and suppliers engaged in the entire value chain from drug substances to drug products to packaging and logistics.
VCI covers drug substances (small molecules and biologics) and drug products (solid dosage, parenterals, and specialty dosage forms) as well as packaging, logistics, and related supply-chain issues.
Subscribe to Value Chain Insights
For article submissions and editorial inquiries:
Patricia Van Arnum
Direct Line: +1-609-582-4254
Main Line: +1-609-208-1888
The Drug, Chemical & Associated Technologies Association (DCAT) is a not-for-profit, global business development association whose unique membership model integrates both innovator and generic drug manufacturers and suppliers of ingredients, development and manufacturing services, and related technologies. We are committed to provide programs, events and services that help our members meet their business objectives, expand their network of customers and suppliers, and gain insight into industry trends, markets, and those issues impacting pharmaceutical development and manufacturing.